Home / Business and Economy / Buffett's Bet Pays Off as UnitedHealth Rebounds 50%

Buffett's Bet Pays Off as UnitedHealth Rebounds 50%

Summary

  • Warren Buffett's Berkshire Hathaway bought 5M UNH shares
  • UNH stock price rebounds 50% from May low to $362.50
  • New CEO Hemsley signs $60M contract, buys $25M in shares
Buffett's Bet Pays Off as UnitedHealth Rebounds 50%

In a significant turnaround, UnitedHealth Group Inc.'s (UNH) stock price has rebounded nearly 50% since August, when Warren Buffett's Berkshire Hathaway purchased 5 million shares. The stock, which had fallen to a low of $245 in May, is now trading at $362.50.

The rebound has been fueled by investor optimism following the return of CEO Stephen Hemsley, who previously led the company between 2006 and 2017. Hemsley, who signed a three-year contract with a potential payout of $60 million in stock, has also bought around $25 million worth of shares, demonstrating his confidence in the company's future.

Analysts are now expecting UnitedHealth to raise its full-year profit forecast, which was previously below estimates. The company is set to report its third-quarter earnings on October 28, 2025, and investors are hopeful that it will return to its long-term profit margin goals by next year. As the company addresses rising healthcare costs, analysts are also anticipating improved company-wide growth in the coming years.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Billionaire Warren Buffett's Berkshire Hathaway purchased 5 million shares of UnitedHealth Group in August 2025, leading to a nearly 50% rebound in the stock price.
The return of CEO Stephen Hemsley, who previously led the company between 2006 and 2017, has boosted investor confidence in UnitedHealth Group's ability to address rising healthcare costs and return to long-term profit margin goals.
Investors are expecting UnitedHealth Group to raise its full-year profit forecast when it reports its third-quarter earnings on October 28, 2025, as the company addresses rising healthcare costs and anticipates improved company-wide growth.

Read more news on